Genomic Characterization of ERBB2-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine

PURPOSE: Biliary tract cancers (BTCs), which include intrahepatic cholangiocarcinoma (ICC), extrahepatic cholangiocarcinoma (EHC), and gallbladder cancer (GBC), have limited treatment options. We sought to comprehensively examine the clinical and molecular characteristics of BTCs with amplification...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCO Precis Oncol
Main Authors: Mondaca, Sebastian, Razavi, Pedram, Xu, Chongrui, Offin, Michael, Myers, Mackenzie, Scaltriti, Maurizio, Hechtman, Jaclyn F., Bradley, Mikaela, O’Reilly, Eileen M., Berger, Michael F., Solit, David B., Li, Bob T., Abou-Alfa, Ghassan K.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2019
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7446346/
https://ncbi.nlm.nih.gov/pubmed/32923849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00223
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados